Fatal attraction: TICs and MDSCs

Thomas WelteLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA;Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA;Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA;Diana Helis Henry Medical Research Foundation, New Orleans, LA, USA

Jeffrey M. RosenDan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA;Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA

Xiang H.-F. ZhangLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA;Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA;Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA;McNair Medical Institute, Baylor College of Medicine, Houston, TX, USACorrespondence[email protected]

References

Welte T, Kim IS, Tian L, Gao X, Wang H, Li J, Holdman XB, Herschkowitz JI, Pond A, Xie G, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol 2016; 18(6):632-44; advance online publication; PMID:27183469; http://dx.doi.org/10.1038/ncb3355
PubMed Web of Science ®Google Scholar
Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149:274-93; PMID:22500797; http://dx.doi.org/10.1016/j.cell.2012.03.017
PubMed Web of Science ®Google Scholar
Plaks V, Kong N, Werb Z. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell 2015; 16:225-38; PMID:25748930; http://dx.doi.org/10.1016/j.stem.2015.02.015
PubMed Web of Science ®Google Scholar
Kaplan RN, Psaila B, Lyden D. Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond. Cancer Metastasis Rev 2006; 25:521-9; PMID:17186383; http://dx.doi.org/10.1007/s10555-006-9036-9
PubMed Web of Science ®Google Scholar
Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM. Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN. Cancer Cell 2009; 16:183-94; PMID:19732719; http://dx.doi.org/10.1016/j.ccr.2009.06.017
PubMed Web of Science ®Google Scholar
Suzuki E, Kapoor V, Jassar AS, Kaiser LR, Albelda SM. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res 2005; 11:6713-21; PMID:16166452; http://dx.doi.org/10.1158/1078-0432.CCR-05-0883
PubMed Web of Science ®Google Scholar
Sharma P, Allison JP. The future of immune checkpoint therapy. Science 2015; 348:56-61; PMID:25838373; http://dx.doi.org/10.1126/science.aaa8172
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Fatal attraction: TICs and MDSCs

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Fatal attraction: TICs and MDSCs

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date